Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 22 871 24 556 22 320 23 964 25 317 26 318
EBITDA 6 541 7 829 - 8 715 9 796 10 258
Operating profit (EBIT) 5 649 6 766 6 079 7 401 8 191 8 720
Pre-Tax Profit (EBT) 2 197 3 796 5 266 6 445 - -
Net income -204 3 232 8 318 5 485 6 670 6 739
P/E ratio -445x 37,0x 14,8x 22,4x 17,6x 16,2x
EPS ( $ ) -0,19 3,13 8,89 6,31 8,01 8,69
Dividend per Share ( $ ) 2,08 2,25 2,58 2,91 3,20 3,48
Yield 2,46% 1,94% 1,96% 2,06% 2,27% 2,46%
Reference price ( $ ) 84,460 115,720 131,430 141,120 141,120 141,120
Announcement Date 01/31/2018
11:25am
02/06/2019
11:25am
01/30/2020
11:25am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2020 (e) 2021 (e) 2022 (e)
Debt 5 613 4 685 10 799 9 018 7 103
Finance - - - - -
Operating income (EBITDA) 6 541 7 829 8 715 9 796 10 258
Leverage
(Debt/EBITDA)
0,86x 0,60x 1,24x 0,92x 0,69x
Capital Expenditure 1 036 1 211 1 200 1 179 1 207
Free Cash Flow (FCF) 4 539 4 314 4 687 6 299 7 166
Book Value Per Share (BVPS) ( $ ) 10,5 9,29 7,37 10,9 12,0
Cash Flow per Share ( $ ) 5,34 5,34 8,48 8,50 -
Announcement Date 01/31/2018
11:25am
02/06/2019
11:25am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 135 494 M $ -
Entreprise Value (EV) 146 292 M $ 144 512 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 22,4x 17,6x
Capitalization / Revenue 5,65x 5,35x
EV / Revenue 6,10x 5,78x
EV / EBITDA 16,8x 14,9x
Yield (DPS / Price) 2,06% 2,27%
Price to book (Price / BVPS) 19,2x 12,9x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 30,9% 32,4%
Operating Leverage (Delta EBIT / Delta Sales) 2,95x 1,89x
Net Margin (Net Profit / Revenue) 22,9% 26,3%
ROA (Net Profit / Asset) 13,4% 17,7%
ROE (Net Profit / Equities) 131% 118%
Rate of Dividend 46,1% 40,0%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   5,01% 4,66%
Cash Flow / Sales 34,0% 32,2%
Capital Intensity (Assets / Sales) 1,71x 1,49x
Financial Leverage (Net Debt / EBITDA) 1,24x 0,92x
EPS & Dividend